FSTR vs ROMA

FSTR exhibits a strong deterministic health profile with a Piotroski F-Score of 7/9 and a conservative debt-to-equity ratio of 0.41. However, there is a severe divergence between its fundamental value (Graham Number: $16.39, Intrinsic Value: $4.83) and its current market price of $29.97. While revenue growth is robust at 25.10%, the company has failed to beat earnings estimates in the last four quarters, with an average surprise of -48.78%. The combination of bearish insider selling and a weak technical trend offsets the strong balance sheet and growth potential.

ROMA exhibits a Piotroski F-Score of 4/9, indicating stable but mediocre financial health, which is heavily contradicted by catastrophic operating margins of -500.84%. The company is trading at an extreme valuation premium with a Price/Book ratio of 29.55 and Price/Sales of 25.04, despite negative ROE and ROA. While the 1-year price performance is exceptionally strong (+415.9%), this appears to be a speculative rally disconnected from fundamental value. The combination of severe losses and a bearish technical trend suggests a high risk of correction.